Supplemental Figure 3 from Clinical Dosing Regimen of Selinexor Maintains Normal Immune Homeostasis and T-cell Effector Function in Mice: Implications for Combination with Immunotherapy
Year: 2023
Type: supplementary-materials
Abstract: Supplemental Figure 3: Degranulation of effector CD8 T cells is affected by selinexor.
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362595097